Luke comes to ACS after serving as the Senior Editor for Cancer Research Communications at the American Association for Cancer Research, where he led the internal effort to launch and develop this new open access journal. Prior to that, he served as Associate Editor for Molecular Cancer Research. Luke’s doctoral and postdoctoral training were both devoted to understanding prostate cancer: his graduate thesis work focused on defining the molecular biology of androgen receptor transcriptional activity, while his postdoctoral training focused on translational research and immunotherapy applications for prostate cancer. Luke brings experience in coordinating and communicating with stakeholders and audiences of diverse backgrounds to his new role as the NPCRT Strategic Director, and he looks forward to working with the NPCRT to benefit patients and their families.